nLIGHT (LASR) Q2 2026 earnings review
Record Top-Line Overshadowed by Severe Supply Chain Shock
nLIGHT delivered a robust Q2, beating expectations with record revenues of $82.6M (+34% YoY) and solid Adjusted EBITDA of $10.7M. The Aerospace & Defense (A&D) segment continues to be a powerhouse, accounting for nearly 70% of total sales. However, the momentum has hit a sudden wall: management disclosed a severe supply chain disruption that will push approximately $17M of product revenue out of Q3. Consequently, Q3 revenue guidance plunged to a midpoint of $70M, implying a brutal sequential deceleration and dragging profitability down with it. While the long-term defense pipeline remains intact, near-term execution risk has spiked significantly.
🐂 Bull Case
Aerospace and Defense revenue surged 41% YoY to $57.3M. New program wins, such as the DoD's Joint Laser Weapon Systems contract, validate nLIGHT's technological moat in high-energy directed systems.
With over $330M in cash and marketable securities (bolstered by the recent Q1 equity raise) and consecutive quarters of positive operating cash flow, the company is well-capitalized to absorb temporary supply chain shocks.
🐻 Bear Case
The inability to ship $17M of product in Q3 exposes critical vulnerabilities in component sourcing. This disruption breaks the company's operating leverage, cratering Q3 EBITDA guidance to just $1-$7M.
nLIGHT remains highly susceptible to the lumpiness of government contracts and supply availability. Even if demand is robust, pushed revenues create quarter-to-quarter earnings volatility that punishes valuations.
⚖️ Verdict: ⚪
Neutral. The underlying thesis—nLIGHT as a premier U.S. directed energy supplier—is intact and validated by Q2 numbers. However, the $17M Q3 supply chain miss is a major near-term penalty that will restrict multiple expansion until resolved.
Key Themes
Supply Chain Crisis Derails Q3
Management explicitly excluded ~$17M in product revenue from their Q3 guidance due to 'supply chain challenges,' pushing these deliveries into future quarters. This is a massive 20% haircut to what Q3 revenue should have been (~$87M), exposing fragility in nLIGHT's manufacturing ecosystem and disrupting their growth trajectory.
Aerospace & Defense Continues to Dominate
A&D remains the undisputed growth engine, accelerating to $57.3M in Q2 (up 41% YoY). This segment now accounts for 69.4% of total revenue. The continued expansion is heavily supported by directed energy scaling and the newly referenced DoD Joint Laser Weapon Systems contract, proving nLIGHT's strategic pivot is working.
Commercial Growth Contradicts 'Exit' Narrative
In recent quarters, management heavily communicated a strategic exit from legacy commercial markets (like cutting and welding) to focus on A&D, bracing investors for a $25M-$30M revenue headwind. Yet, Q2 data contradicts this: Industrial grew 24% YoY ($12.0M) and Microfabrication grew 17% YoY ($13.3M). This creates confusion: are these temporary 'last-time buys' artificially inflating Q2 results, or is the company failing to cleanly execute its strategic exit, thereby splitting resources?
Margin Compression Looms in Q3
The supply chain delay isn't just a top-line issue; it destroys factory absorption. While Q2 delivered an impressive 31.1% GAAP gross margin, Q3 guidance calls for overall margins to compress to 24%-30%. This demonstrates how highly sensitive nLIGHT's profitability is to volume throughput.
Inherent Operating Leverage Proven in Q2
When volumes execute smoothly, the financial model shines. In Q2, a 34% rise in total revenue translated to a 63% reduction in Net Loss (-$1.3M vs -$3.6M YoY) and nearly doubled Adjusted EBITDA ($10.7M vs $5.5M YoY). Products gross margin held strong at 41.2%, proving that if nLIGHT can solve its supply chain issues, structural profitability is achievable.
High-Power Directed Energy Tech Advantage
nLIGHT continues to leverage its vertically integrated technology stack. Success with platforms designed for high-power directed energy and optical sensing continues to separate the company from legacy industrial laser peers, enabling them to win critical, mission-specific defense contracts.
Other KPIs
Strong structural improvement YoY, up from 38.5% in 25Q2. This was driven by higher A&D mix. However, this metric decelerated slightly from 44.6% in 26Q1, and is expected to decelerate further to a midpoint of 37% in 26Q3 due to the delayed $17M in shipments.
Stable quarter-over-quarter and up massively YoY, primarily reflecting the $191M equity raise from Q1. This fortress balance sheet is critical right now, as it allows the company to invest in capacity and weather working capital swings tied to the current supply chain delays.
A massive reversal from the $1.4M outflow in the same period last year. Achieved through better profitability metrics and $9.2M generated from favorable changes in deferred revenues.
Guidance
Decelerating aggressively. The midpoint of $70M implies a -15% sequential decline from Q2, and a meager +5% YoY growth (down from +34% YoY in Q2). This is entirely driven by the $17M supply chain push-out.
Reversing. The midpoint of $4.0M is a severe drop from the $10.7M achieved in Q2 and is lower than the $7.1M achieved in the prior year's Q3. This highlights the negative operating leverage incurred when scheduled manufacturing volumes are delayed.
Decelerating. The midpoint of 27% is down roughly 400 basis points from Q2's 31.1%, suffering from under-absorption of fixed manufacturing costs due to the missing $17M in shipments.
Key Questions
Supply Chain Specifics
Can you identify the specific components causing the $17M shipment delay in Q3? Are these sole-sourced components, and what is the visibility into resolving this bottleneck by Q4?
Commercial Segment Contradiction
Industrial and Microfabrication segments both grew double-digits YoY. Does this reflect final 'last-time buys' related to your strategic exit from legacy markets, or has underlying demand stabilized in a way that alters your previous plan to divest resources from this segment?
Margin Recovery Timeline
Assuming the delayed $17M in product revenue ships in Q4 or later, should we expect an outsized margin benefit in those periods as factory absorption artificially spikes, or will expediting costs offset those gains?